Cite
HARVARD Citation
Furie, R. et al. (n.d.). AB0373 TREATMENT OF SLE WITH THE IMMUNOPROTEASOME INHIBITOR KZR-616: RESULTS FROM THE FIRST 4 COHORTS OF THE MISSION STUDY, AN OPEN-LABEL PHASE 1B DOSE ESCALATION TRIAL. Annals of the rheumatic diseases. pp. 1486-1487. [Online].